Knowing that a patient has a BRCA mutation can influence treatment decisions. For instance, PARP inhibitors, a class of drugs, have shown effectiveness in treating cancers associated with BRCA mutations. Additionally, knowing the genetic status can help in choosing between various surgical options and chemotherapy regimens.
